{
    "eid": "2-s2.0-85076266348",
    "title": "Feasibility technique of low-passage in vitro drug sensitivity testing of malignant pleural effusion from advanced-stage non-small cell lung cancer for prediction of clinical outcome",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Advanced stage non-small cell lung cancer",
        "In vitro drug sensitivity testing",
        "Malignant pleural effusion",
        "Precision medicine"
    ],
    "authors": [
        "Chanida Vinayanuwattikun",
        "Ornjira Prakhongcheep",
        "Sucharat Tungsukruthai",
        "Korrakod Petsri",
        "Prapassorn Thirasastr",
        "Nophol Leelayuwatanakul",
        "Pithi Chanvorachote"
    ],
    "citedby-count": 5,
    "ref-count": 19,
    "ref-list": [
        "Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials",
        "Genotyping KRAS and EGFR mutations in Greek patients with non-small-cell lung cancer: Incidence, significance and implications for treatment",
        "Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs",
        "Pemetrexed plus platinum for patients with advanced non-small cell lung cancer and interstitial lung disease",
        "Previous immune checkpoint inhibitor treatment to increase the efficacy of docetaxel and ramucirumab combination chemotherapy",
        "Current status and perspectives of patient-derived xenograft models in cancer research",
        "In vitro assays for the evaluation of drug resistance in tumor cells",
        "Genomic evolution of cancer models: Perils and opportunities",
        "New response evaluation criteria in solid tumours: Revised RECIST guideline",
        "A simple practice guide for dose conversion between animals and human",
        "Drug sensitivity prediction with high-dimensional mixture regression",
        "Pharmacogx: An R package for analysis of large pharmacogenomic datasets",
        "Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer",
        "Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer",
        "Cancer cell line encyclopedia consortium and genomics of drug sensitivity in cancer:Pharmacogenomic agreement between two cancer cell line data sets",
        "Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity",
        "Patient-derived xenografts undergo mouse-specific tumor evolution",
        "Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn Academic Advancement"
    ]
}